Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IL-12 enhances IL-2 function by inducing CD25 expression through a p38 mitogen-activated protein kinase pathway.

T Nguyen1, R Wang, J H Russell

  • 1Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110, USA.

European Journal of Immunology
|May 23, 2000
PubMed
Summary

A mutant interleukin-2 (IL-2) protein, Q126D, promotes T cell proliferation but not activation-induced cell death (AICD). Interleukin-12 (IL-12) enhances Q126D function by upregulating the IL-2 receptor alpha chain (CD25).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of western redcedar (Thuja plicata Donn) heartwood components by HPLC as a possible screening tool for trees with enhanced natural durability.

Journal of chromatographic science·2007
Same author

Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias.

Clinical immunology (Orlando, Fla.)·2001
Same author

Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase.

Molecular and cellular biology·2001
Same author

Genetic control of pathogenic mechanisms in autoimmune demyelinating disease.

Journal of neuroimmunology·2000
Same author

The role of fas ligand in vivo as a cause and regulator of pathogenesis.

Current opinion in immunology·2000
Same author

Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease.

Journal of neuroimmunology·2000

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Interleukin-2 (IL-2) is crucial for T cell proliferation and activation-induced cell death (AICD).
  • A previously studied IL-2 mutant, Q126D, induces T cell proliferation but not AICD.
  • The IL-2 receptor alpha chain (CD25) is known to be important for IL-2 function.

Purpose of the Study:

  • To investigate the mechanism by which the IL-2 mutant Q126D partially signals.
  • To determine the role of CD25 in mediating the effects of Q126D.
  • To explore the synergistic effects of IL-12 with Q126D on T cell responses.

Main Methods:

  • Utilized T cells with and without CD25 expression.
  • Administered IL-2 mutant Q126D and/or IL-12.

Related Experiment Videos

  • Employed a p38 mitogen-activated protein (MAP) kinase inhibitor (SB203580) to block CD25 upregulation.
  • Assessed T cell proliferation and AICD sensitivity.

    • Main Results:

    • The partial signaling of Q126D is due to its failure to upregulate CD25.
    • IL-12 enhances Q126D-mediated AICD sensitivity and proliferation by upregulating CD25.
    • This IL-12 and Q126D synergy is dependent on CD25 and is abrogated in CD25-deficient T cells.
    • IL-12-induced CD25 upregulation is mediated via p38 MAP kinase signaling.

    Conclusions:

    • CD25 upregulation is critical for IL-2 function, particularly at physiological concentrations.
    • IL-12 can enhance IL-2 function by upregulating CD25 in a p38 MAP kinase-dependent manner.
    • Targeting CD25 modulation offers a potential strategy to enhance T cell-mediated immune responses.